Enanta Pharmaceuticals Inc. buy Jefferies Financial Group Inc.
Start price
01.10.25
/
50%
€9.05
Target price
01.10.26
€17.04
Performance (%)
20.44%
Price
29.01.26
€10.60
Summary
This prediction is currently active. The prediction currently has a performance of 20.44%. This prediction currently runs until 01.10.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Enanta Pharmaceuticals Inc. | -1.852% | -1.852% |
| iShares Core DAX® | -1.432% | 0.000% |
| iShares Nasdaq 100 | -0.386% | -0.595% |
| iShares Nikkei 225® | 1.448% | 5.269% |
| iShares S&P 500 | 0.114% | -0.217% |
Comments by Jefferies_Financial_ for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals (NASDAQ:ENTA) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $20.00 price target on the stock.
Ratings data for ENTA provided by MarketBeat
Stopped prediction by Jefferies_Financial_ for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.05
01.10.25
01.10.25
€17.04
01.10.26
01.10.26
20.44%
29.01.26
29.01.26
